Other languages Caplin Point Laboratories Limited

Equities

CAPLIPOINT

INE475E01026

Delayed Bombay S.E. Other stock markets 09:58:49 10/05/2024 BST			5-day change	1st Jan Change
1,280 ^INR	+0.43%		-1.45%	-5.62%

05-06	Caplin Point Laboratories Gets Colombian Drug Regulator's Approval for Soft Gel Capsules Unit in India	MT
04-16	Caplin Point Arm Gets US FDA Final Nod for Ofloxacin Ophthalmic Solution	MT

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Caplin Point Laboratories Gets Colombian Drug Regulator's Approval for Soft Gel Capsules Unit in India	05-06
Caplin Point Unit Receives US FDA Nod for Eye Treatment Medication	03-28
Caplin Steriles Limited, A Subsidiary of Caplin Point Laboratories Limited Gets USFDA Approval for Ketorolac Tromethamine Ophthalmic Solution	03-28
Caplin Point Laboratories Arm Starts Operations of Oncology Facility at Kakkalur, India	03-27
Caplin One Labs Limited, a Wholly Owned Subsidiary of Caplin Point Laboratories Limited Successfully Completes New Oncology (Anti-Cancer) Facility, Commences Operations	03-27
Caplin Point Laboratories Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	02-09
Caplin Point Laboratories to Invest INR7 Billion in Tamil Nadu, India	01-08
Caplin Point Unit Gets US FDA Final Approval for Generic Ear Infection Drug	01-08
Caplin Point Laboratories Limited Announces Resignation of Hero Velladurai as President, R&D	12-14
Caplin Point Laboratories Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023	11-09
Caplin Point Laboratories Limited Approves Final Dividend for the Year Ended March 31, 2023	22/09/23
Caplin Point Unit's Injectable and Ophthalmic Plant in India Gets VAI Classification from US FDA	04/09/23
Caplin Point Laboratories Limited Reports Earnings Results for the First Quarter Ended June 30, 2023	07/08/23
Caplin Point Laboratories Limited Recommends Final Dividend for the Financial Year Ended March 31, 2023	07/08/23
Caplin Point Laboratories to Incorporate Step-Down Subsidiary in US	03/08/23
Caplin Point Unit Gets US FDA Nod for Muscle Relaxant	12/06/23
Caplin Steriles Limited Gets United States Food and Drug Administration Approval for Cisatracurium Besylate Injection USP	12/06/23
Caplin Point Gets Four Observations from US FDA After Inspection of Injectable Unit at Gummidipoondi, India	01/06/23
Caplin Point Laboratories Limited Approves Interim Dividend for the Financial Year 2022-23	27/05/23
Caplin Point Laboratories Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2023	27/05/23

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Caplin Point Laboratories Limited

Equities

CAPLIPOINT

INE475E01026

Other languages

Filters